In alignment with our strategic development plan, we are pleased to announce that the new subsidiary Alfasigma Deutschland GmbH with headquarter in Munich is operative, starting from 1st October 2022.
This new opening enhances Alfasigma presence on the international market, strengthening the future growth of our company.
Sabine Kerum has joined Alfasigma to take over the new position of Country Manager and Managing Director of Alfasigma Deutschland, reporting to Wojciech Smoczynski, West Europe Regional Director.
Sabine graduated in Pharmacology and brings to Alfasigma more than 20 years of pharmaceutical experience.
She started her professional path in Otsuka where she remained more than 15 years increasing her responsibility till becoming Business Unit Director. After Otsuka, Sabine entered SHIRE Deutschland as Busines Unit Director of different therapeutical areas then she covered the position of General Manager in Orphalan.
Thanks to her vast experience, Sabine will help Alfasigma Deutschland to achieve its ambitious goals in developing the business.